Cycle Pharmaceuticals Floats $466 Million Bid to Acquire Vanda Pharmaceuticals
- June 07, 2024
Cycle Pharmaceuticals Ltd. is offering to buy Vanda Pharmaceuticals, Inc. in an all-cash transaction valued at $466 million, the company announced June 6.
ARTICLE TAGS
You must be logged in to access this content.